Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Shares Outstanding (Diluted Average): 2021-2023

Historic Shares Outstanding (Diluted Average) for Aytu Biopharma (AYTU) over the last 3 years, with Jun 2023 value amounting to $3.3 million.

  • Aytu Biopharma's Shares Outstanding (Diluted Average) rose 117.72% to $5.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $5.5 million, marking a year-over-year increase of 117.72%. This contributed to the annual value of $3.3 million for FY2023, which is 127.22% up from last year.
  • As of FY2023, Aytu Biopharma's Shares Outstanding (Diluted Average) stood at $3.3 million, which was up 127.22% from $1.5 million recorded in FY2022.
  • In the past 5 years, Aytu Biopharma's Shares Outstanding (Diluted Average) registered a high of $16.7 million during FY2021, and its lowest value of $1.5 million during FY2022.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $3.3 million (2023), whereas its average is $7.2 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first slumped by 91.22% in 2022, then skyrocketed by 127.22% in 2023.
  • Over the past 3 years, Aytu Biopharma's Shares Outstanding (Diluted Average) (Yearly) stood at $16.7 million in 2021, then crashed by 91.22% to $1.5 million in 2022, then skyrocketed by 127.22% to $3.3 million in 2023.